EUVIMEDEUVIMED entdecken
Crossref

“Design and Characterization of Porous Floating Beads of Lafutidine”

Sarfaraz Md Sarfaraz Md, Irfan Alam Shabbir Khan, H. Doddayya H. Doddayya

Journal of Research in Pharmaceutical Science · 2024

DOI: 10.35629/2995-10110517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Research in Pharmaceutical Science, 2024. Verfasst von Sarfaraz Md Sarfaraz Md und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of present research work was to design and characterize porous floating beads of lafutidine a second-generation H2–receptor antagonist. Using the emulsion gelation method, Lafutidine porous floating beads were meticulously crafted, incorporating hydrophilic polymers such as sodium alginate (serving as the gelling agent), along with hydroxypropyl methylcellulose K15M, hydroxypropyl methylcellulose K4M and Carbopol 934p as polymers. Calcium carbonate was introduced as the gas-generating agent, while calcium chloride played the crucial role of the cross-linking agent. The effect of different formulation variables was also studied. The beads were evaluated for particle size, surface morphology, percentage yield, drug entrapment efficiency, drug content, swelling index, buoyancy study and in-vitro drug release. Fourier-transform infrared spectroscopy and differential scanning calorimetry studies were carried out for compatibility studies. The micromeritic parameters of floating beads of lafutidine were within acceptable limits. The particle size was between 1210.53 ± 1.07 to 1249.46 ± 0.98 μm. When observed under scanning electron microscopy, the floating beads were spherical in shape with distinct pores inside. The percent yield was 76.04 ± 2.59 to 92.43±1.91%, entrapment efficiency was 70.91 ± 1.49 to 82.40 ± 2.41%, drug content was 71.85 ± 1.79 to 83.96 ± 1.83% and the swelling index was 67.34 ± 1.24 to 86.90 ± 1.51%. The buoyancy time was 43 ± 0.8 to 59 ± 0.5 s and the total buoyancy time was more than 12 h. The in-vitro dissolution studies showed 84.53 to 98.84% drug release in 12 h. F5 was selected as the optimized formulation as it released 98.84% of the drug in 12 h at a controlled rate, which is desired for diseases like peptic ulcer. All the formulations followed zero order kinetics indicating drug release by non-fickian release mechanism. Drug and excipient compatibility studies showed no interaction was observed.

Zitieren

APA

Md, S. M. S., Khan, I. A. S., & Doddayya, H. D. H. (2024). “Design and Characterization of Porous Floating Beads of Lafutidine”. Journal of Research in Pharmaceutical Science. https://doi.org/10.35629/2995-10110517

Vancouver

Md SMS, Khan IAS, Doddayya HDH. “Design and Characterization of Porous Floating Beads of Lafutidine”. Journal of Research in Pharmaceutical Science. 2024. doi:10.35629/2995-10110517

BibTeX
@article{Md2024,
  author = {Md, Sarfaraz Md Sarfaraz and Khan, Irfan Alam Shabbir and Doddayya, H. Doddayya H.},
  title = {“Design and Characterization of Porous Floating Beads of Lafutidine”},
  journal = {Journal of Research in Pharmaceutical Science},
  year = {2024},
  doi = {10.35629/2995-10110517}
}
Kostenlos starten →